BUSINESS BRIEFING / PHARMACEUTICALS
Times Wire Reports
Swiss pharmaceutical giant Roche said it had completed its $46.8-billion takeover of San Francisco biotech firm Genentech. Roche, which already held 55.7% of Genentech stock, said it acquired a further 37.5% of shares by the offer deadline Wednesday.
